News

What is the extent of disparities in cancer clinical trials among low- and middle-income countries?

ESMO 2025: Study finds COVID-19 mRNA vaccine sparks immune response to fight cancer

ESMO 2025: ADC improves outcomes for patients with advanced triple-negative breast cancer who are ineligible for immune checkpoint inhibitors

ESMO 2025: Drug combo cuts risk of death in advanced prostate cancer by 40%

ESMO 2025: New generation of antibody-drug conjugates shows promise in early-stage disease

ESMO 2025: Novel treatment combination improves progression-free survival in metastatic, oestrogen-receptor-positive HER-2-negative breast cancer

ESMO 2025: Trial results show belzutifan shrinks rare neuroendocrine tumours and improves symptoms

ESMO 2025: Dual targeted therapy shows promise in previously treated advanced kidney cancer

ESMO 2025: Chemo combination boosts overall survival in patients with EGFR-mutant NSCLC

Study reveals how bacteria in tumours drive treatment resistance in cancer

Personalised breast cancer therapy: A new treatment approach for patients with limited tamoxifen efficacy

After cancer: Study explores caring-healing modalities for survivors